MHT: timing is critical.
In: Australian Journal of Pharmacy, 2021-05-02, S. 12-20
academicJournal
Zugriff:
Most women reach menopause between the ages of 45 and 55, but the years leading up to menopause can cause symptoms similar to, or even more intense than, menopause. is is due to hormone fl uctuations as the ovaries begin to slow down and run out of eggs. DOI: 10.1111/1471-0528.16393 EARLY MENSTRUATION LINKED TO INCREASED MENOPAUSE SYMPTOMS 18 | WOMEN'S HEALTH Autumn 2021 "Regarding the risk of VTE, oestrogen doses used in MHT are far lower than in the oral contraceptive pill - which many women considering MHT have taken for decades." WOMEN'S HEALTH Autumn 2021 | 19 Hormone therapy // MENOPAUSE BH5703 WHS Estrogel Pro ad update-270x206-v1.indd 1 BH5703 WHS Estrogel Pro ad update-270x206-v1.indd 1 22/2/21 3:17:53pm 22/2/21 3:17:53pm Importantly, it is the safest type of hormone therapy in women at risk of VTE. 12 | WOMEN'S HEALTH Autumn 2021 Experts agree menopausal hormone therapy (MHT) is safe and effective for women with no absolute contraindications - but timing is critical. [Extracted from the article]
Copyright of Australian Journal of Pharmacy is the property of Australian Pharmaceutical Publishing Co. Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
MHT: timing is critical.
|
---|---|
Zeitschrift: | Australian Journal of Pharmacy, 2021-05-02, S. 12-20 |
Veröffentlichung: | 2021 |
Medientyp: | academicJournal |
ISSN: | 0311-8002 (print) |
Sonstiges: |
|